Interclean Shanghai

UBERDOC Launches UBERDOC for Hospitals to Significantly Reduce Hospital Administrative Costs

UBERDOC Launches UBERDOC for Hospitals to Significantly Reduce Hospital Administrative Costs

UBERDOC, the leading direct-to-consumer digital healthcare platform, announced today the launch of UBERDOC for Hospitals, a new way for hospitals to streamline access to care through a price transparent model.

On average, more than 30 percent of hospital and healthcare costs are due to the administrative burden associated with making appointments. From answering phones to gathering large amounts of complex insurance information and authorizations, hospitals have needed to shift resources away from direct patient care. In addition, it has become challenging to train and retain administrative staff to keep up with the constant changes in insurance regulations. UBERDOC for Hospitals allows patients the option to connect directly to the specialist of their choice without delays or network restrictions, driving new direct-pay patients with an easy-to-use, cost-effective, online appointment scheduler.

“COVID-19 has shown us how patient access is affected when staff is unavailable to answer phones,” said Dr. Paula Muto, CEO and founder of UBERDOC. “We want hospitals to think differently, recognizing more patients are looking for convenient and affordable options for their care.”

The UBERDOC model reduces bad debt for hospitals, as patients provide immediate payment upon scheduling the appointment. This additional revenue stream provided by UBERDOC is also compliant with the latest Price Transparency regulations from CMS, allowing hospital systems to easily show the public they are willing to accept new patients to their top specialists at a transparent price.

This is the latest in a series of offerings from UBERDOC to change the healthcare status quo. UBERDOC recently announced that it is proven to reduce emergency care for non-emergencies by the Validation Institute, indicating that hospitals and employers alike must provide priority access to care to minimize current and future health issues. UBERDOC was also recently recognized as the top startup in digital healthcare during the Startup Showcase at InnovatorMD Global Summit in January of this year.

With a vast network of more than 3,000 physicians, UBERDOC is dedicated to connecting best-in-class board-certified doctors to patients for the care they need, when they need and at a transparent price.

ABOUT UBERDOC

UBERDOC is an innovative healthcare platform that connects patients with available board-certified doctors and specialists for in-person and telemedicine appointments at a transparent price. We provide direct access with no phone calls, no waiting, no insurance approvals or referrals needed and no surprise bills. UBERDOC is convenient and easy to use for both doctor and patient.

Cisco launches health digitisation programme in Japan

Digital India Health Summit & Innovation Awards

Japan, the world’s third-largest economy, and Cisco, a worldwide leader in technology, announced a collaboration framework through Cisco’s Country Digital Acceleration (CDA) Program to drive mass-scale digitization across Japan in support of its Society 5.0 vision and towards an inclusive recovery from the global COVID-19 pandemic.

The program in Japan was unveiled at virtual event attended by Guy Diedrich, Vice President and Global Innovation Officer at Cisco, and Ichiro Nakagawa, Vice President and Head of Japan at Cisco, Wayoh Suzuki, Chairman, Cisco Japan, with remarks via video from Takuya Hirai, Japan’s Minister of State for Digital Transformation, the Minister of State for the Social Security and Tax Number System and Minister in charge of Information Technology Policy.

The CDA program is strategically aligned with the Japanese Government’s digital agenda and its vision with Society 5.0 vision, which aims to stimulate Japan’s economic growth, enhance the quality of life, and create a society where everyone can fully reap the benefits of digital transformation.

“I would like to express my sincere respect for Cisco’s program to support digitalization around the world. In Japan, Cisco has been promoting a number of projects to support digitalization in areas such as IT talent development, network security, industry, government, education, and healthcare. This direction is exactly what we are aiming for,” said Minister Hirai.

“As business leaders it is our responsibility to play a role in stepping up to the challenges of inequity, and to create new pathways to economic prosperity, spark new ideas and ignite innovation. We are delighted to be collaborating with the Government of Japan to help bring to life key initiatives that will help build an inclusive future for all, and further propel Japan into the digital age,” said Guy Diedrich.

In collaboration with industry, academia and government, the Japan CDA program will accelerate various initiatives, with specific focus on the following areas:

Secure Public Infrastructure: Cisco will support the development of secure network platforms for Government and Critical Social Infrastructure. It will also build a cybersecurity human resource development program to develop the next generation of cybersecurity professionals in the country. This is critical as cybersecurity is the foundation of all digitization initiatives and there exists a significant shortage of talent to fill cybersecurity roles.

Digital Schools: Cisco will help advance the digitization of education and help bridge the digital divide that exists, in terms of equity of access to online resources. Initiatives will be in close alignment with the GIGA School initiative, whose goal it is to ensure that each student has access to one digital device and high-speed broadband internet, while introducing online education for children tailored to their preferences and developmental stages.

Advanced Remote Work: Cisco will work alongside enterprises, including small and medium sized businesses, to help them adapt to the ongoing changes in the way we work, triggered largely by the pandemic. Many of these changes are here to stay and with companies looking at a more widely distributed workforce, the need for right collaboration tools and underlying cybersecurity infrastructure has never been more important.

COVID-19 Response and Digital Healthcare: In response to the continued spread of COVID–19, Cisco will help private, public, and not-for-profit sector organizations accelerate their transition to remote functionality to maintain operational continuity, with a specific focus on Digital Healthcare.

Supply Chain: Cisco will co-innovate alongside Japanese companies in areas such as Artificial Intelligence, Internet of Things, Data Analytics, Edge Computing etc. to help businesses in Japan improve productivity, accelerate innovation, provide better customer experiences, and improve overall competitiveness.

Regulatory Reform and Digital Society: Cisco will work with regulatory authorities and advise on innovative approaches to promoting a digital society while adhering to environmental, safety, and security considerations. In addition, the Cisco will aim to re-imagine the fan experience in the context of live entertainment and events.

5G Infrastructure: Cisco will consult and collaborate with an array of stakeholders to build the underlying core infrastructure required to roll out 5G networks across the country. The connectivity, speed and low latency provided by 5G networks will further accelerate innovation, create better outcomes for businesses and experiences for consumers.

“The Japanese Government has laid the foundation for future growth by accelerating its digital policy and agenda and Society 5.0 vision. For it to succeed we need structural innovation, infrastructure development, wide-spread adoption and use of cutting-edge technologies, as well as training and development of next-generation of IT workforce. At Cisco Japan, we are committed to playing our role in helping turn this vision into a reality,” said Ichiro Nakagawa.

Cisco’s CDA team collaborates with national, state, and local governments in 40 countries around the world to accelerate their national digitalization agendas, co-develop cutting-edge solutions, and deliver beneficial services to their citizens faster and more effectively. CDA has over 900 active or completed projects spanning several verticals in close partnership with government, industry and academia.

About Cisco

Cisco is the worldwide leader in technology that powers the Internet. Cisco inspires new possibilities by reimagining your applications, securing your data, transforming your infrastructure, and empowering your teams for a global and inclusive future. Discover more on The Network and follow us on Twitter.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

GIANT Health is expanding in 2021. Announcement of European Health-Tech Innovation Week

GIANT Health is expanding in 2021. Announcement of European Health-Tech Innovation Week

European Health-Tech Innovation Week – sponsored by GIANT Health – takes place from 17-21 May 2021 and is five 1-day hybrid conferences and exhibitions across Europe’s leading healthcare innovation regions; successfully driving improved healthcare outcomes and business collaboration by showcasing & championing Europe’s best health-tech innovations.

Participating cities are Barcelona, Berlin, Liverpool, Paris, and Stockholm. Each 1-day festival is both a physical and virtual format, providing valuable face-to-face and virtual networking and promotional opportunities, learning, and collaboration for the entire European health-tech community including businesses, investors, government agencies, scientists, and academics. The virtual / fully digital elements of the event enable robust collaboration and engagement for businesses around the world.

  • A one-day conference and tradeshow showcasing latest innovations in healthcare technology.
  • Each day will be hosted on our own virtual event technology platform, allowing remote participants from around the world.
  • Championing the best of each of these countries for international best-practice benchmarking, including our very successful
  • Inbound Trade Mission programme.
  • International best practice for COVID-19 hygiene and social distancing will be maintained at our in person events.
  • In case of further restrictions due to COVID-19, Event will be fully virtual.

About GIANT Health:
“Europe’s largest, most valuable annual festival of health-tech innovation” – Financial Times

The GIANT (Global Innovation and New Technology) Health Event is an unmissable innovation festival with over 25 conferences, 450 speakers, immersive workshops, and Beanstalks (a global startup competition for prizes). Our vision is to improve the health and well-being of people around the world, by promoting healthcare innovation and supporting health-tech entrepreneurs. In 2021, we will be holding two events aimed at creating opportunities to connect people who would not have crossed paths otherwise.

Oxford University launches Covid-19 vaccine study on children

RSPH calls for quick measures to keep child vaccine decline in check

The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine.

The university said that previous trials of its ChAdOx1 nCoV-19 jabs, which are being produced by AstraZeneca and also have a tie-up with the Serum Institute of India, have shown that it is safe, produces strong immune system responses and has high efficacy in all adults.

From Friday, it would be extending its trials to assess if children and young adults aged 6-17 years also show a good immune response to coronavirus from it.

While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination, said Andrew Pollard, Professor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford vaccine trial.

These new trials will extend our understanding of control of SARS-CoV2 to younger age groups, he said.

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

The COVID-19 pandemic has had a profound negative impact on the education, social development and emotional well-being of children and adolescents, beyond illness and rare severe disease presentations, said Rinn Song, Paediatrician and Clinician-Scientist, Oxford Vaccine Group.

It is therefore important to collect data on the safety and the immune response to our coronavirus vaccine in these age groups, so that they could potentially benefit from inclusion in vaccination programmes in the near future, he said.

After the launch of the trial funded by the National Institute for Health Research (NIHR) and AstraZeneca this week, the first vaccinations are expected during the course of this month.

This study will play an important role in helping to protect children in the future. We’ve already seen that the vaccine is safe and effective in adults, and our understanding of how children are affected by the coronavirus continues to evolve, said Grace Li, Paediatric Clinical Research Fellow, Oxford Vaccine Group.

The university said it has teamed up with three partner sites in London, Southampton and Bristol for this extended vaccine trial.

 

Experian Health expedites access to Precise ID for Epic customers to address COVID-19 identity verification challenges

As part of its ongoing efforts to assist the healthcare industry with pandemic-related challenges through the power of data and analytics, Experian Health is collaborating with Epic to make its identity proofing solution, Precise ID®, available faster to all Epic clients.

Experian Health’s work with Epic, one of the largest health information software companies at the scale of 250 million patient records worldwide, leverages a decade-long integration to address an emerging, critical need to support a more efficient and secure COVID-19 testing and vaccination process. Together, the companies are providing the customers with a state-of-the-art identity proofing, risk-based authentication solution with an expedited implementation process.

“We are very pleased to be collaborating with Epic to make this essential tool readily available for healthcare organizations so they can ensure their patient authentication tool is turn-key,” said Tom Cox, general manager, Experian Health. “With the uptick in fraud since the pandemic started, coupled with the need to efficiently verify patient identities in activities tied to Covid-19 testing and vaccine distribution, we know our authentication solution can aid providers with both security and speed.”

This new rapid response implementation is driven by best practices embedded in Epic MyChart®. Precise ID offers several operational benefits including streamlining patient portal enrollment, eliminating manual work processes for staff, and preventing long call center wait times for patients. Last year, it verified nearly 1 billion identities assisting individuals in their journey to access healthcare information, verify employment status, and access personal financial applications and websites. The product is used by more than 2,000 organizations spanning many industries in addition to healthcare such as government, financial services, retail and insurance.

This offering complements several other solutions Experian Health has launched for the healthcare industry since the pandemic began, including a free Payer Alerts Portal that provides the latest COVID-19 and telehealth payer policy alerts, and the free COVID Outlook & Response Evaluator Model, a heat map of geographical populations across the U.S. most susceptible to developing cases of severe COVID-19.

About Experian Health

At Experian Health, we collaborate with more than 3,400 hospitals and 7,300 other healthcare organizations representing 500,000-plus providers — almost 60 percent of the market — to provide data-driven platforms to empower our clients to make smarter business decisions, boast a better bottom line and foster stronger patient relationships. Our industry-leading solutions include revenue cycle management, identity management, patient engagement and care management.

Part of Experian, the world’s leading information services company, our Experian Health business is known for its patient access heritage, advanced data insights and patent-pending Touchless Workflow™ which help providers, labs, pharmacies and other risk-bearing entities power opportunities in today’s consumer-driven healthcare environment.

Experian has 17,800 people operating across 45 countries, and every day we’re investing in new technologies, talented people and innovation to help all our clients maximize every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

Sensyne Health licenses MagnifEye technology to Excalibur Healthcare Services for use with lateral flow diagnostic tests

Sensyne Health licenses MagnifEye technology to Excalibur Healthcare Services for use with lateral flow diagnostic tests

Sensyne Health plc, the UK Clinical AI company, announces that it has signed an exclusive licence and development agreement with Excalibur Healthcare Services Limited (“Excalibur”) to apply Sensyne’s MagnifEye system for use with Excalibur’s proprietary lateral flow rapid diagnostic tests across a range of indications including its COVID-19 antigen test currently being marketed in the UK and across Europe. In recent trials, the Excalibur COVID-19 antigen lateral flow diagnostic test has out-performed other competing lateral flow tests with its speed, sensitivity and reliability. The test has been approved by the UK regulator for mass population screening in symptomatic and asymptomatic people.

The MagnifEye system (“the System”) is Sensyne’s proprietary software application available as both a smartphone app and a web application, that uses a cloud-based deep learning algorithm to automate the reading and analysis of different diagnostic tests including lateral flow tests. The System has been adapted to Excalibur’s already high-performance lateral flow Antigen test. The System trains users to administer a lateral flow test, then interpret that test and provide a shareable digital certificate that validates the training of the user, the test result and resulting health status. It is anticipated that this will facilitate frequent testing, both for COVID-19 and a range of other conditions.

Excalibur will market the System alongside its current and future portfolio of lateral flow tests globally to customers in both the public and private sectors, with Sensyne acting as its critical clinical AI technology supplier, underpinning each new product. Excalibur will pay Sensyne a royalty each time the System is used to read a lateral flow test with a minimum guaranteed royalty sum of £4.8 million payable over the first two years of the agreement. The analytical capacity of the System at launch will match Excalibur’s current lateral flow test manufacturing capacity of approximately three million tests per day (approx. 1.1 billion test per year).

The initial focus will be on use of MagnifEye for COVID-19 antigen testing, followed by its potential application in new lateral flow diagnostic tests for serology, cancer and other disease conditions that Excalibur is currently developing. Beyond this agreement, Excalibur and Sensyne will seek to collaborate on the development of further projects that combine Excalibur’s expertise in the development and marketing of high-quality diagnostic tests with Sensyne’s expertise in the development and supply of software systems using clinical AI.

 

Hospital for Special Surgery Hospital Launches the First FDA Approved Digital Pathology Platform

Hospital for Special Surgery Hospital Launches the First FDA Approved Digital Pathology Platform

Hospital for Special Surgery (HSS), the world’s leading academic medical center specializing in orthopedics, rheumatology, and related disciplines, has become the first facility in the country to launch a cutting-edge technology for the digitization of pathology slides allowing pathologists to use digital images as primary means of diagnosis.

The system, called the Sectra Digital Pathology Solution, lets HSS pathologists scan and upload slides into a single repository where others in the care team — from orthopedic surgeons and radiologists to rheumatologists and endocrinologists — can view them, along with radiologic images that also are housed in the system. This facilitates access for specialists from across HSS to share and discuss tissue samples in real time, making care more efficient and improving clinicians’ ability to diagnose and treat their patients. Additionally, HSS clinicians and others in the care team can review the digital slides individually, simultaneously or slides shared by other hospitals to consult on complex cases.

“HSS is the first hospital in the United States to have successfully integrated a high-resolution digital scanner [Leica] with the pathology Laboratory Information System [Epic/Beaker] and the enterprise-wide PACS [Sectra] in a way that allows pathologists to use digital images for primary diagnosis,” said Thomas W. Bauer, MD, PhD, pathologist-in-chief at HSS, who led the digital pathology initiative.

Allowing surgeons, radiologists, and other physicians to view high-resolution digital images of scanned microscope slides can significantly improve patient care, Dr. Bauer said. “Access to digital pathology images, side by side with radiology images on the same enterprise-wide PACS, enables correlation between different types of studies and promotes efficient discussion about complicated cases.”

In addition, instantly viewing digital images from previous procedures will be much easier than retrieving old microscope slides from long-term storage for re-review, he added.

“The implications of the move to digital pathology are significant for patients everywhere,” Dr. Bauer said. For example, because HSS pathologists are experts in musculoskeletal pathology, they frequently receive cases for consultation from other hospitals.

“Receiving digital images electronically from hospitals with their own scanners will facilitate consultative review, and has the potential to greatly reduce turnaround time,” he added.

“Digital pathology is the natural next step in the digital transformation of healthcare,” said Douglas N. Mintz, MD, a radiologist at HSS who specializes in musculoskeletal imaging and who was instrumental in developing the platform with Dr. Bauer. “We can compare what we see on an image with what was seen on biopsy. It also facilitates the correlation between radiology and pathology, which is particularly important in the diagnosis and treatment of musculoskeletal neoplasms.”

Array of High-Tech Tools

“The scanned images are extremely high quality and, when used in combination with the Leica scanner and Sectra viewer, are considered by the FDA to be equivalent to conventional microscopy for making a primary diagnosis,” explained Dr. Bauer.

HSS, ranked #1 in the world for Orthopedics by Newsweek and has been ranked #1 in the United States for orthopedics for 11 consecutive years by U.S. News & World Report, began its digital pathology initiative in 2017, and started working with Sectra technology in 2018, when it was still in the development phase. Initially, the goal was to use the system in a limited fashion, for particularly challenging cases in which clinicians had questions about pathology reports. But the COVID-19 pandemic prompted the FDA to grant the company emergency use authorization for its imaging platform, allowing HSS to speed up its transition to digital pathology.

“It is gratifying to see our vision of Integrated Diagnostics come to fruition after a long software development and integration journey,” said Inderpal Kohli, assistant vice president, IT Clinical Applications at HSS. In addition to other benefits, the solution offers HSS clinicians a familiar user interface and workflows, enabling ease of use and broader adoption across the enterprise.

Beyond patient care, digital pathology will also have an immediate impact on student and resident education, both at HSS, where the technology already is being used to help trainees, and elsewhere.

“We and other hospitals anticipate incorporating digital pathology into a variety of educational conferences available online, in which residents and fellows learn from more senior faculty by reviewing digital images,” Dr. Bauer said. “As other hospitals convert their systems to digital imaging, they will be able to better take advantage of the expertise of the faculty at HSS and other centers of excellence, thereby promoting physician education and improving the care of patients around the world.”

HAS Technology Group set to Save UK Healthcare Sector Billions of Pounds with SOTI MobiControl

HAS Technology Group, a global technology solutions provider with a strong heritage in health and social care, is using SOTI MobiControl, part of the SOTI ONE Platform, to reduce the risk of the UK’s aging population from falling and enabling the UK’s health sector to avoid the associated costs. ARMED (Advanced Risk Monitoring for Early Detection), one of HAS’ solutions since 2016 and a registered medical device, utilizes wearable technology to collect key metrics associated with frailty and risk of falling, potentially saving the UK healthcare sector billions each year.

Wearable Devices Monitoring A Patient’s Condition Reduces Risks and Saves Money
When a patient falls and injures themselves, there is a significant likelihood of that same patient falling again in the future. According to a WHO Global Report on falls prevention in older age, 34% of those over 65 are at risk of falls, raising significant concerns regarding the future demands of the health and care services.

ARMED utilizes wearable devices to monitor a patient’s condition 24/7 and then uses this data to feed into their machine learning models. HAS was in search of a solution that would allow ARMED to help escalate risks in advance and create the triggers to allow for a quicker and more accurate diagnosis based on the early warning signals the data provided. They were keen to provide further customization to their solution and, with an aging population, it became imperative to also facilitate battery management.

Overhauling Manual Processes with Enterprise Mobility Management
The ARMED platform extracts data from smart watches, manufactured by Polar. With a customized SOTI MobiControl application controlling the smartphone, the Polar is paired with a smartphone via Bluetooth and the data is transferred from the watch to the phone. This data is captured, and Medical Grade Device machine learning algorithms are applied to forewarn of medical issues and changes in the behaviour of elderly patients. This also helps healthcare practitioners to prioritize resources accordingly.

SOTI MobiControl is customized to remind the patient to put their phone and watch on charge via voice alerts if their battery is below 50%. The platform then monitors the connection between the phone and watch, guaranteeing the data is constantly being transferred. Finally, SOTI MobiControl allows patients to open or restrict certain apps and communicate on the phone without needing to interact with the device.

“ARMED is now a registered medical device and this step, along with machine learning, is significantly contributing to understanding the longer-term impacts of health and lifestyle changes in a more preventative manner,” said Brian Brown, Director ARMED at HAS Technology Group. “We are excited for the future with SOTI and making a huge difference to the quality of life for individuals.”

As an example, a fractured hip in the UK costs approximately £32,000 per person, while a fracture arm/elbow costs approximately £8,000 per person. With over 500 devices in the field, SOTI MobiControl has enabled HAS to focus on reducing falls and enabling the UK’s health sector to avoid the associated costs. With falls costing the UK healthcare sector an estimated £5 billion each year, there is now an increased interest in falls prevention technology.

“HAS Technology has created real value for ARMED customers, helping them to drive efficiencies through dynamic uses of data,” said Sarah Edge, Regional Director of Enterprise Mobility, UK at SOTI. “We are proud to enable ARMED customers to securely manage their devices all in one place and deliver actionable insights that reduce the risk of injury for so many.”

For more information on how HAS Technology Group is leveraging falls prevention technology using SOTI MobiControl, read our latest case study.

About SOTI
SOTI is the world’s most trusted provider of mobile and IoT management solutions, with more than 17,000 enterprise customers and millions of devices managed worldwide. SOTI’s innovative portfolio of solutions and services provide the tools organizations need to truly mobilize their operations and optimize their mobility investments. SOTI extends secure mobility management to provide an integrated solution to manage and secure all mobile devices and connected peripherals in an organization.

About SOTI MobiControl
SOTI MobiControl makes Enterprise Mobility Management (EMM) easier than ever before. It empowers companies to securely manage any device or endpoint with any form factor and any operating system throughout their entire lifecycle; from deployment to retirement. It controls all aspects of business mobility, from tracking physical assets to managing apps and content, all while keeping devices and data, safe and secure.

About HAS Technology Group
HAS Technology offers a variety of services, including CM, PAMMS and ARMED, which provide holistic prevention, commissioning and a delivery package of solutions. The group is leading the way with an innovative approach to social care technology solutions to ensure ongoing improvements in delivery and quality of care.

 

 

Medics.Academy and Ethiopian Medical Women’s Association to address health worker shortfall across Ethiopia

COVID-19 frontline healthcare workers at risk of mental health problems

Medics.Academy – a revolutionary UK company delivering global access to world-leading medical education and the Ethiopian Medical Women’s Association (EMeWA) have signed a partnership agreement to help women physicians in Ethiopia.

The project will help EMeWA – an organisation established by female physicians in Ethiopia – to fulfil its vision to establish an excellence center for women physicians through one of its main thematic areas of professional development.

As part of the collaboration Medics.Academy will be investing £250,000 GBP (over 12 million Ethiopian Birr) in building a new learning community to provide digital access to training and support a target of 70% of female physicians in Ethiopia over the next 5 years – identified by the World Health Organization (WHO) as one of the 57 countries in the world with a chronic shortage of health workers.

The unique collaboration has been endorsed by the Ministry of Health of Ethiopia and, by championing access to online education, aims to drive digital transformation to help address the country’s health workforce needs, promote professional development and achieve greater representation and leadership of women in medicine.

Globally, the COVID-19 crisis has led to a significant shift to digital adoption that will likely persist post-pandemic. While there has been high growth in the adoption of education technology in recent years, this move has been deeply accelerated by COVID-19. Remote learning has become a vital part of education delivery and all across the world has been enrolled into the ‘new normal’.

Dr Alastair McPhail CMG OBE, UK Ambassador to Ethiopia, said: “We are very proud of the partnerships between the UK and Ethiopia on health. The coronavirus pandemic has stretched health systems and healthcare workers to their limits.”

“I hope that this new partnership will inspire and upskill female doctors across Ethiopia, directly contributing to high quality, equitable health services and ending the avoidable deaths of mothers and children.”

The pandemic has also brought pressures on health systems around the world and highlighted already existing health shortages. This includes a projected shortfall of 18 million health workers worldwide by 2030. In Ethiopia, WHO has been supporting the Ministry of Health to help increase the number of health workers and improve their skills since the beginning of the pandemic.

Dr Lia Tadesse, Minister of Health of the Federal Democratic Republic of Ethiopia, added: “Professional Development of women in healthcare is an area of priority for us in Ethiopia. Even though women make up the larger proportion in the healthcare industry, they are not visible in leadership as we want them to be due to the various challenges they face to advance their professional growth. As a result, we have few women representation in places where their voice matters and their contributions are vital. This partnership will help change this by creating an innovative learning hub that will help women foster their leadership role and advance in their careers.”

Over the last four years EMeWA has been working on professional development, rights of women physicians and community development to bring a holistic advancement of women in the health sector. The organization has been providing training on soft skills and mentorship for women physicians in their early careers and has a webinar series where major topics in the health sector are discussed.

EMeWA has also been increasing the visibility of women physicians who are exemplary in their practice through its Celebrating Women project which served as an inspiration for many and highlighted the increasing role of women in the healthcare system of the country.

Going forward, Medics.Academy will be working with the organisation to deliver tailored education programmes that can drive improvements in skills and diversify the country’s healthcare workforce.

Dr. Senayit Beyene, the President of EMeWA commented: “The project will help deliver quality and affordable learning opportunities which are both accredited and acceptable both locally and internationally. It will also create the platform to establish strong and practical networks and connections around the world for collaborations and mentorship. Our ultimate goal is to develop a learning community that acknowledges and builds on the different skill sets of its members at all levels. I am confident that Medics.Academy’s pioneering education platform will help to plug this gap in a sustainable manner.”

Empowering women in health leadership is a core strategic focus for Medics.Academy. The company supported the establishment of the Women in Healthcare Leadership (WIHL) programme to increase opportunity for representative leadership in the UK’s NHS. The innovative programme has since expanded overseas, supporting healthcare professionals and building a supportive platform that champions inclusivity at leadership level.

Dr Johann Malawana, Chief Executive Officer at Medics.Academy, said: “Over the last four years, we have sought to formalise various initiatives, to promote diversity of thought and ideas and help to create a global community of healthcare leaders of the future. Inclusivity is absolutely key to leadership and this collaboration is reflective of our long-term strategy to foster frontline innovation and increase women’s representation in healthcare globally. Our overall objective is to work towards removing gender and other barriers, to pursuing leadership roles in Healthcare.”

Well Health Inc. Announces COVID Vaccination Self-Scheduling Capabilities Through Multiple Industry-Leading Partners

Cerner Launches AI-Powered Command Center Dashboard for COVID-19 Response

Well Health Inc., a Saas digital health leader in patient communications and 2021 Best in KLAS winner in Patient Outreach, announces COVID Vaccination Self-Scheduling available through third-party partnerships with industry-leading, HIPAA-compliant self-scheduling systems. COVID Vaccination Self-Scheduling will help healthcare providers accelerate vaccination efforts and engage large patient populations — both current EHR and non-EHR patients — at scalable price points, as low as $250 per vaccination location per month.

“To date, WELL Health technology has successfully helped providers facilitate 4 million COVID vaccine-related messages and more than 1 million COVID vaccine appointments,” said Guillaume de Zwirek, CEO and Founder, Well Health Inc. “We want to accelerate those numbers and know we cannot do it alone, especially when time and lives are on the line. By partnering with industry-leading self-scheduling partners, we can offer healthcare providers superior technology, multiple options to meet their unique workflows, and competitive pricing, all while staying focused on what WELL does best: exceptional patient communications.”

Well Health announces COVID vaccination self-scheduling capabilities through multiple industry-leading partners

  • Allowing patients to self-schedule both appointments, which has proven to be more efficient and faster than manually scheduling appointments.
  • Improving appointment slot utilization so all vaccine doses and appointments are maximized.
  • Ensuring second dose appointments are followed up on and self-scheduled, ensuring complete vaccination protection.
  • Engaging as many patients as possible with secure messaging to existing EHR patients, as well as non-EHR patients.
  • Successfully reaching underserved communities, who could be outside of a health system’s current EHR, is critical in fighting this pandemic, combating health inequity and ensuring the most vulnerable patients are protected.

WELL Health continues to offer new solutions and strategic partnerships to help healthcare providers solve critical COVID-related problems. In addition to COVID Self-Scheduling, WELL Health recently launched the Vaccine Deployment Program (VDP). WELL Health’s VDP allows providers to rapidly execute secure patient messaging for COVID-19 vaccine communications, including patient education, vaccine safety reassurance, appointment scheduling (both doses), adverse event monitoring and more, and can be implemented in as little as five days.

About WellTM Health Inc.
WELLTM Health is a SaaS digital health leader in patient communications and the 2021 Best in KLAS winner in Patient Outreach. WELL Health’s intelligent communications hub is the only two-way digital health solution engaging patients throughout their entire care experience. WELL Health enables conversations between patients and their providers through secure, multilingual messaging in the patient’s preferred communications channel: texting, email, telephone, and web chat. WELL Health facilitates more than 1 billion messages for 31 million patients annually. By unifying and automating disjointed communications across healthcare organizations, WELL Health reduces unnecessary provider stress and potential errors, while increasing patient visits and loyalty.

 

Translate »